Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

A novel drug combination targeting LSD1 and GSK3 shows promise in treating acute myeloid leukemia by promoting cell ...

“It’s akin to giving T cells X-ray vision,” Dr. Klebanoff says. In the lab, Dr. Abdel-Wahab and Dr. Klebanoff showed that when mice with AML were treated with the TCR therapy, they had a significant ...

May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...

The combination cures about 95% of APL cases, but there remains a pressing need to identify similar strategies for the treatment of other AML patients. One way to circumvent the differentiation ...

and response to induction therapy. Researchers performed blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with AML presenting between January 2012 and ...

A study from the University of Cambridge has found that metformin, an inexpensive treatment for type 2 diabetes, could potentially prevent a form of acute myeloid leukaemia (AML) while studying ...

Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure – – Combination of ziftomenib and imatinib shows robust and ...